Target intelligence / Profile preview

Bacterial adhesin (Uroepithelial) (FimH/PapG)

Target
FimH/PapG
Molecular classification
Bacterial surface protein, Lectin, Adhesin
01

Overview

Bacterial adhesins, such as FimH and PapG, are critical virulence factors that mediate the attachment of uropathogenic bacteria to the host uroepithelium (Sauer et al., 2000). FimH, located at the tip of Type 1 fimbriae, specifically recognizes mannosylated uroplakins (UP1a) on bladder cells, facilitating colonization and invasion (Wu et al., 1996). PapG, found on P-fimbriae, binds to galabiose-containing glycolipids, which is particularly important for colonization of the upper urinary tract and the development of pyelonephritis (Dodson et al., 2001). These adhesins allow bacteria to resist the mechanical flushing of urine, a primary host defense mechanism. Therapeutic targeting of these proteins, primarily through competitive inhibitors like D-mannose or synthetic mannosides (e.g., GSK3882347), aims to block bacterial attachment and promote clearance (Sivick et al., 2022). This anti-adhesive approach is a promising alternative to traditional antibiotics, potentially reducing the selective pressure for antimicrobial resistance (Spaulding et al., 2017).

Other names
Uropathogenic adhesinFimbrial adhesinType 1 fimbriae adhesinP-fimbriae adhesinPili adhesinUroepithelial-binding adhesin
02

Mechanism of action

Competitive inhibition of bacterial binding to host uroepithelial receptors (e.g., uroplakins or glycolipids), preventing colonization and facilitating bacterial clearance by urine flow.

03

Biological functions

Cell adhesionBacterial colonizationBiofilm formationPathogenesis
04

Disease associations

Urinary tract infectionCystitisPyelonephritisUrosepsis
05

Safety considerations

Alteration of commensal microbiomeLimited efficacy against non-fimbriated strainsPotential for compensatory expression of alternative adhesins
06

Interacting drugs

D-Mannose

3 more in the full profile.

07

Biomarkers

Bacterial fimbrial gene expressionUrine bacterial countFimH-positive E. coli strains

Beyond the preview

Go deeper on Bacterial adhesin (Uroepithelial) (FimH/PapG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial adhesin (Uroepithelial) (FimH/PapG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call